Integrative Multimodal Profiling of TAp73 and DNp73 Reveals Isoform-Specific Transcriptomic Coregulator Landscapes in Cancer Programs
Biomolecules · 2025
DOI: 10.3390/biom16010063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Steffen Möller und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Gene Therapy and Cancer Research, Rostock University Medical Center, 18057 Rostock, Germany. Hauptthemen laut MEDLINE: Tumor Protein p73, Transcriptome, Melanoma, Neoplasms. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG), German Cancer Aid, German Federal Ministry of Education and Research (BMBF).
Abstract (Originalsprache)
(1)
Background
The transcription factor p73 exists in multiple isoforms with divergent functions in cancer. While DNp73 promotes stemness, epithelial–mesenchymal transition (EMT), and metastasis, the tumor-suppressive isoform TAp73 can also switch to promoting cancer progression. How isoforms sharing the same DNA-binding domain produce divergent outcomes remains unclear. (2)
Methods
Here, we performed CUT&RUN in combination with JASPAR, transcriptomics, proteomics, patient survival and gene expression data to map genome-wide and promoter-associated DNA-binding and coregulatory transcription factor (coTF) profiles of TAp73α and DNp73β in melanoma cells. (3)
Results
Systematic screening for motif enrichment in cancer hallmark gene sets revealed TAp73- and DNp73-specific coTF repertoires with distinct functions. We identified a coregulator signature for EMT genes enriched for both isoforms that has tumor context-dependent effects on survival and correlates with unfavorable patient prognosis. Of these EMT-associated coTFs, PATZ1 was validated as a novel direct interactor of DNp73β. (4)
Conclusions
Our results provide a comprehensive reference map of p73 isoform-specific binding and coregulator recruitment and establish a workflow to model their influence on cancer reprogramming with implications for AI-based individualized therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Experimental Gene Therapy and Cancer Research, Rostock University Medical Center, 18057 Rostock, Germany.
- Department of Life, Light and Matter, University of Rostock, 18055 Rostock, Germany.
ORCID-Profile: Steffen Möller
Förderung
- Deutsche Forschungsgemeinschaft (DFG)
- German Cancer Aid
- German Federal Ministry of Education and Research (BMBF)
- Deutsche Krebshilfe
- FORUN program of Rostock University Medical Center
Zitieren
APA
Möller, S., Spitschak, A., Murr, N., & Pützer, B. M. (2025). Integrative Multimodal Profiling of TAp73 and DNp73 Reveals Isoform-Specific Transcriptomic Coregulator Landscapes in Cancer Programs. Biomolecules. https://doi.org/10.3390/biom16010063
Vancouver
Möller S, Spitschak A, Murr N, Pützer BM. Integrative Multimodal Profiling of TAp73 and DNp73 Reveals Isoform-Specific Transcriptomic Coregulator Landscapes in Cancer Programs. Biomolecules. 2025. doi:10.3390/biom16010063
BibTeX
@article{Mller2025,
author = {Möller, Steffen and Spitschak, Alf and Murr, Nico and Pützer, Brigitte M},
title = {Integrative Multimodal Profiling of TAp73 and DNp73 Reveals Isoform-Specific Transcriptomic Coregulator Landscapes in Cancer Programs},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom16010063}
}
EUVIMED